loadpatents
Patent applications and USPTO patent grants for Kammerer; Friedrich-Johannes.The latest application filed is for "medicaments to combat autoimmune diseases".
Patent | Date |
---|---|
Medicaments to combat autoimmune diseases Grant 5,679,709 - Bartlett , et al. October 21, 1 | 1997-10-21 |
Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use Grant 5,532,259 - Bartlett , et al. * July 2, 1 | 1996-07-02 |
Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use Grant 5,494,911 - Bartlett , et al. February 27, 1 | 1996-02-27 |
Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus Grant 5,268,382 - Bartlett , et al. December 7, 1 | 1993-12-07 |
Pharmaceutical preparation and method of treatment Grant 4,351,841 - Kammerer , et al. September 28, 1 | 1982-09-28 |
5-Methylisoxazole-4-carboxylic-(4-trifluoromethyl)-anilide Grant 4,284,786 - Kammerer , et al. August 18, 1 | 1981-08-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.